Not Available
Award amount
$100,000Program and phase
SBIR · Phase IAward year
2000Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- TARGEPEUTICS INC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- JN8ARN7JB9M5
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Development of GB13 for the Treatment of Pediatric Diffuse Intrinsic Pontine Glioma
- TAS::75 0849::TAS TOPIC 255 DEVELOPMENT OF GB13 AS A NOVEL GLIOBLASTOMA THERAPY
Research funding history
3 SBIR/STTR records share this UEI (2000–2022). Reported award amounts total $629,785. Reported amounts are not federal obligations.
Phases: Phase I
Agencies: Department of Health and Human Services